Penserra Capital Management LLC Gh Research PLC Transaction History

Penserra Capital Management LLC

  • $4.61 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$8.99 - $19.87 $16,964 - $37,494
-1,887 Reduced 8.1%
21,400 $213,000
Q1 2022

May 13, 2022
SELL
$15.48 - $23.98 $124,536 - $192,919
-8,045 Reduced 25.68%
23,287 $322,000
Q4 2021

Feb 15, 2022
BUY
$14.1 - $27.9 $84,120 - $166,451
5,966 Added 23.52%
31,332 $730,000
Q3 2021

Nov 15, 2021
BUY
$16.51 - $23.68 $418,792 - $600,666
25,366 New
25,366 $559,000

Others Institutions Holding GHRS

# of Institutions
32
Shares Held
27.8M
Call Options Held
2.8K
Put Options Held
3.8K
View Full List

About GH Research PLC

GHRS Quotes by TradingView
  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $380M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email